New cancer drug destroyed 100% of tumors in trial, but it’s not quite the miracle the media claims
On Monday, the New England Journal of Medicine published the results of a new treatment for a specific form of cancer. In that trial, all 12 patients that completed treatment with the new drug, called dostarlimab, had what was called a “100% response.” That is, every one of these patients saw their tumors completely eradicated.
Drug trails, especially early trials, often give murky results.